Home  >  Research  >  Labs  >  Genome Biology and Genetics Program  >  RARE DISEASE GENETICS AND FUNCTIONAL GENOMICS

RESEARCH OVERVIEW

The Rare Disease Genetics and Functional Genomics Research Group works to identify and understand the genetics underlying rare diseases. The Group has a particular focus on the genetics of severe and early-onset diseases, in particular neuromuscular diseases. Prior to an accurate genetic diagnosis, families and patients are in the dark. They do not know what is causing the disease, what the risk of recurrence is and what the prognosis might be.

These severe diseases often result in the child’s death before birth or in the first years of life.  Those who survive have severe disabilities. For families, the anguish is beyond words.  Often, there is no family history of the condition, and no known disease-causing genetic variant.  It is estimated that ~50% of patients remain without a molecular diagnosis.

Making the genetic diagnosis is the turning point for these families. It provides them with answers; it provides options around family planning; it enables precision medicine.  It also enables them to find their “genetic village”, others who have been similarly affected: a source of great comfort and support.  It can spare families the heartache of having another affected child if they wish.

The Team receives samples from patients across Australia and overseas and works closely with clinical specialists, including neurologists, paediatricians, pathologists and geneticists. A wide range of approaches are used to identify novel disease genes and genotype-phenotype expansions including exome sequencing, whole genome sequencing, RNA-seq (including single cell and single nuclei). Functional validation of candidate variants includes RNA studies, protein studies and cell-based assays (including CRISPR-mediated gene editing). Studies in model organisms are performed via collaborations with world experts working on zebrafish and mouse models of human disease.

The Research Team also works incredibly collaboratively with Diagnostic Genomics at PathWest, the Australasian Referral Centre for the genetic diagnosis of neuromuscular diseases. This collaboration allows for rapid translation of research findings into diagnostic testing and synergies between diagnostics and research.

Dr Gina Ravenscroft

Dr Gina Ravenscroft

Rare Disease Genetics and Functional Genomics

Read more

Artwork by student Ms Hayley Goullee showing the key themes involved in rare disease gene discovery and functional genomics.

Published in Beecroft et al. 2020 The Impact of next-generation sequencing on the diagnosis., treatment and prevention of hereditary neuromuscular disorders. Mol Diagn Ther. PMID: 32997275; DOI: 10.1007/s40291-020-00495-2

LATEST NEWS

Perkins Intrapreneur 40under40 winner targets medical grant reform

Congratulations to Perkins group leader Dr Gina Ravenscroft, who was announced as a Business News 40under40 finalist for the First Among Equals award, and winner of the Intrapreneur Category Award. Announced at the Awards' 2021 Gala Dinner, Gina was recognised for her innovative work and immense contributions to genetic disease research…

Read More

Waking up silent genes

Testing proven cancer research on a devastating childhood condition For parents whose child has been diagnosed with Prader-Willi Syndrome (PWS), their concerns usually start when their baby fails to thrive. They might be floppy with weak muscle tone, have a weak cry and a poor ability to suckle and need…

Read More

WA leading in $20 million pre-pregnancy genetic carrier screening research

WA is leading the way in a national $20 million pre-pregnancy screening study testing volunteer couples for genetic mutations that cause devastating diseases. The program known as Mackenzie’s Mission, co-led by Harry Perkins Institute of Medical Research geneticist Professor Nigel Laing AO, aims is to test 1300 WA couples by…

Read More

I'M LOOKING FOR

RESEARCH PROJECTS

TEAM MEMBERS

PUBLICATIONS